Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS)
Crossref DOI link: https://doi.org/10.1007/s12029-014-9680-1
Published Online: 2015-02-24
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bodoky, György
Scheulen, Max E.
Rivera, Fernando
Jassem, Jacek
Carrato, Alfredo
Moiseyenko, Vladimir
Vynnychenko, Ihor
Prausová, Jana
Van Laethem, Jean-Luc
Cascinu, Stefano
Ajani, Jaffer A.
Text and Data Mining valid from 2015-02-24
Version of Record valid from 2015-02-24
Article History
First Online: 24 February 2015